Lege Artis Medicinae

[The Art of Cézanne – An Exhibition in Budapest ]

NAGY Zsuzsa

DECEMBER 18, 2012

Lege Artis Medicinae - 2012;22(12)

COMMENTS

0 comments

Further articles in this publication

Lege Artis Medicinae

[„Three dimensions in diabetes - one cooperation, two pharmaceutical companies, three compounds” - EASD, Berlin, 1st October 2012.]

NÉMETH Éva

Lege Artis Medicinae

[Some thoughts at the 50th anniversary of my medical graduation]

BOGA Bálint

Lege Artis Medicinae

[The importance of balneotherapy in osteology]

BENDER Tamás, KULISCH Ágota, KOVÁCS Csaba, HORVÁTH Katalin, GYARMATI Noémi, TEFNER Ildikó

[The authors overview the role of hydroand balneotherapy in osteology. As Hungary is very rich in thermal-mineral water, this kind of therapy has a great importance in the rehabilitation of locomotor diseases. In the past years, an increasing number of data have been published about the immunomodulatory, metabolic and analgesic role of hydro- and balneotherapy. Although balneotherapy’s mechanism of action has not been clarified yet, a number of reviews and metaanalyses have found that hydro- and balneotherapy have a beneficial effect on locomotor diseases. The majority of these articles - many of them written by Hungarian authors - discusses the treatment of arthrosis. Furthermore, an increasing amount of data is available on calcium supplementation with mineral water. In this paper, we discuss the role of hydro- and balneotherapy in the therapy of osteological diseases, on the basis of the available evidence.]

Lege Artis Medicinae

[Cost minimization analysis of basal insulin analogues in the treatment of type 2 diabetes]

MERÉSZ Gergő, TABÁK Gy. Ádám, KALÓ Zoltán

[INTRODUCTION - Basal insulin analogues are essential drugs for the treatment of type 2 diabetes mellitus. Basal insulin analogues have been shown to reduce the frequency of hypoglycaemia versus NPH insulin, and thus may be beneficial in the treatment of type 2 diabetes. Here we present a cost-minimisation analysis of basal insulin analogues, comparing insulin glargine and insulin detemir available in Hungary. METHODS - A literature review was conducted to identify randomized, controlled clinical trials with a duration of 12 weeks or more in which a direct comparison of insulin glargine and insulin detemir was made in patients with type 2 diabetes. In a meta-analysis of the eligible trials, the following endpoints were investigated: metabolic status, body weight, frequency of hypoglycaemia, insulin doses administered and the number of insulin injections required. If a high heterogeneity (I2>75%) was found, meta-regression was performed to identify the underlying reasons. The funder’s perspective was applied in the cost-minimization analysis by taking into account the cost of the drug and of medical devices necessary for its administration, based on the daily number of insulin injections. RESULTS - No further studies were found in addition to those included in a metaanalysis published by The Cochrane Library. On the basis of three eligible studies, insulin detemir was injected more frequently compared with glargine (weighted mean difference: 0.42 95% CI 0.14-0.69 injections/day). High heterogeneity was present in case of two endpoints: the incidence of overall hypoglycaemia per patient-year (I2=83%), and daily basal insulin dose in units per body weight (I2=94%). The reason for the high heterogeneity in hypoglycaemia rates was not identified by meta-regression; however, the difference in insulin doses per body weight was negatively associated with body weight (-0.027 IU/kg per 1 kg, 95%CI: -0.051; -0.004). On the basis of the present meta-analysis and meta-regression, our calculations suggest that treating an average weight (90 kg) patient with type 2 diabetes with insulin glargine would result in an annual cost reduction of 93 452 HUF compared with insulin detemir by employing gross public drug prices. CONCLUSION - On the basis of the available clinical evidence, insulin glargine might be a cost-saving alternative of insulin detemir in an average-weight patient with type 2 diabetes. In an era of scarce resources, the role of therapeutic alternatives offering cost savings with the same efficacy become more important. The generalisability of our conclusions might be influenced by potential differences in the manufacturers’ claw-back rate of detemir vs glargine insulin.]

Lege Artis Medicinae

[Is a Good Death Possible? ]

HEGEDÛS Katalin

All articles in the issue

Related contents

Hungarian Radiology

[Paraclinical “röntgen” forum Measurements on x-ray equipments: towards quality and safety - Budapest, June 9th, 2009.]

GÁSPÁRDY Géza

Lege Artis Medicinae

[Daumier and Cézanne – Exhibitions in Budapest]

NAGY Zsuzsa

Lege Artis Medicinae

[Practical considerations in the state-of-the-art management of ankylosing spondylitis]

SZÁNTÓ Sándor, SZEKANECZ Zoltán

[Ankylosing spondylitis is an inflammatory rheumatic disease characterized by inflammation of the spinal and sacroiliacal joints, which causes chronic back pain and ultimately spinal stiffness, impaired motility, and deformity. Until the last decade, treatment mainly consisted of a combination of physical therapy and non-steroidal anti-inflammatory drugs, but recently tumor necrosis factor-α inhibitors revolutionized therapy and improved clinical outcomes. Tumor necrosis factor-α inhibitors effectively control inflammation of the sacroiliacal and spinal joints as shown by improved signs symptoms, and functions, magnetic resonance imaging findings, and reduction of acute phase reactants. Whether these drugs are capable of preventing radiographic progression and structural damage has, however, to be clarified in future studies. This review aims to highlight recent progress in the treatment of ankylosing spondylitis, and to provide recommendations for its management.]

Lege Artis Medicinae

[Surrealistic Art from the Perspective of Psychoanalysis]

GYIMESI Anna

Lege Artis Medicinae

[Advances in sleep diagnostics]

HORVÁTH Róbert

[Despite the insufficient financial support, the number of the laboratories for sleep diagnostics and the examined patients are rising. The CPAP (Continuous Positive Airway Pressure) equipment playing the main role in the treatment of the obstructive sleep apnoe syndrome (OSAS) is recently available from three neurological centres (Budapest, Debrecen, Pécs). These centres can prescribe the machine as a ”model experiment” with 85% support given by the State Health Care. The increase of the number of the licensed hospitals is expected in the near future, the only condition is the polysomnography background. Differential diagnostics (narcolepsy, RLS, PLMS, sleepdependent laryngospasm, disorders of the circadian rhythm) and the follow-up of the CPAP using patients (indication, contraindication, compliance, CPAP pressure setting, CPAP therapy control) have been emphasized.]